Skip to content
Still have doubts about menopause or hormone therapy? Clear them up with a doctor, free of charge, also by video call.Doubts about menopause? Clear them up with a doctor for free.

Menopause in Italy: the numbers

In Italy, about 17 million women are in menopause or perimenopause, according to an estimate by Federfarma reported by Fondazione Onda. The menopause usually arrives between the ages of 45 and 55, at around 51 on average. This page brings together the most recent Italian data on women in menopause: who they are, at what age the menopause arrives, what symptoms they have, how much the menopause affects work and how many receive treatment. Every number comes with its year, and the sources are listed at the bottom of the page. Where an official figure does not exist, we say so.

Last updated: October 2026.

The five key numbers

  • About 17 million women in Italy are in menopause or perimenopause, according to an estimate by Federfarma reported by Fondazione Onda in 2025. Women aged 45 to 59 number almost 7 million, according to ISTAT at 1 January 2025.
  • 76% of women aged 45 to 55 report sleep disturbances and 73% hot flushes, in a 2024 survey by Onda.
  • Almost 7 in 10 working women aged 45 to 65 say their symptoms affect their performance to a medium or high degree, in a 2025 survey by Onda.
  • 37.7% of working women aged 45 to 65 have not talked about their symptoms with anyone at work, in the same survey.
  • No official figure says how many Italian women use hormone therapy; in a Censis survey of women aged 45 to 65, published in 2021, it was 7.6%.

How many women are in menopause in Italy?

Women in Italy in menopause and perimenopause number about 17 million: this is an estimate by Federfarma, which Fondazione Onda reports in its press release of 28 May 2025 for the presentation to the Chamber of Deputies of the policy document “Salute e benessere in menopausa”. On 30 June 2026, again at the Chamber, Maria Rosaria Campitiello, head of the Department of Prevention at the Ministry of Health, spoke of about 17 million women in menopause and of 450,000 who enter this stage of life every year.

The policy document also reports ISTAT's January 2024 population data: about 13.5 million women aged 45 to 75 live in Italy, and another 4.3 million are over 75. These are all the women of that age, not only those in menopause.

Women aged 45 to 59, the ages at which the menopause arrives, numbered 6,976,515 at 1 January 2025: 2,116,264 aged 45 to 49, 2,399,714 aged 50 to 54, 2,460,537 aged 55 to 59.

How long women live, and how many years they spend after the menopause

Life expectancy at birth for a woman in Italy was 85.6 years in 2024, according to ISTAT's final life table (the March 2025 estimate was 85.5), and the estimate for 2025 is 85.7. A woman who turns 51, the average age of menopause, has on average another 35.6 years ahead of her (35.7 in the 2025 estimate): this is our measure of the years spent in postmenopause, an approximation, because the table covers all 51-year-old women, including those who are not yet in menopause or who reached it earlier. The table applies the mortality of 2024 at every age: if survival keeps improving, as ISTAT's projections assume, the number of years will be higher for the women of today.

Life expectancy at birth of women in Italy: the 2024 value and the ISTAT projections up to 2080.
Life expectancy at birth, women in ItalyYears
2024, life table85.6
2030, projection86.1
2040, projection86.8
2050, projection87.6
2080, projection89.6

The projections, median scenario with a base date of 1 January 2025, take women's life expectancy at birth to 87.6 years in 2050, two years more than in 2024. ISTAT does not publish projections at age 51, so for the years after the menopause we only have today's value. For women, the years expected in good health at birth are instead 58.0 in 2025, against 60.2 for men (provisional estimate): women live 4.0 years longer than men on average, but spend 2.2 fewer of them in good health.

At what age does the menopause arrive?

In Italy the menopause usually arrives between the ages of 45 and 55, according to the Istituto Superiore di Sanità (ISS), and at around 51 on average: in three Italian studies the average age at menopause ranges from 50.2 to 51.2 years. About 8–10% of women reach menopause before the age of 45, from natural or induced causes. In an Italian study of women aged at least 55 who had attended menopause clinics, 1.8% had reached it before 40. The first symptoms of premenopause appear before the menopause, for most women after the age of 40, while periods are still present.

Age at menopause in Italy: the age at which it usually arrives, the average age, early menopause and who measured each value.
Age at menopause in ItalyValueWho measured it
Age at which it usually arrivesbetween 45 and 55ISS, 2020
Average age at natural menopause51.2 yearsProgetto Menopausa Italia, 31,834 women from menopause clinics, data 1997–2003
Average age among women seen by their GP50.2 years1,123 GPs, 16,916 women, 1997
Self-reported average age51 yearsOnda, women in menopause among the 626 interviewed, 2014
Menopause before 458–10% of womenISS, 2020
Menopause between 40 and 457.1%Progetto Menopausa Italia, 15,253 women from menopause clinics, data 1997–1999
Menopause before 401.8%Progetto Menopausa Italia, 15,253 women from menopause clinics, data 1997–1999

What is the average age of menopause in Italy?

Between 50.2 and 51.2 years, in the three Italian studies we found, with data collected between 1995 and 2003. The largest, Progetto Menopausa Italia, collected between 1997 and 2003 the data of 31,834 women with spontaneous menopause who had attended menopause clinics: the average age was 51.2 years, and it did not change markedly between women born in different years. In the ICARUS study, of 4,300 women from menopause clinics, it was 50.9 years. In a 1997 survey of 16,916 postmenopausal women seen by 1,123 GPs it was 50.2 years.

The most recent figure is an Onda survey: in June 2014 it interviewed 626 women aged 45 to 65 in pharmacies, in nine regions, and those who were already in menopause had reached it at 51 on average. After 2014 we did not find a new Italian measurement. The same value, 51 years, is the average age given for the United Kingdom by the British Menopause Society in 2026.

How many women reach menopause before 45 or before 40?

About 8–10% of women reach menopause before the age of 45, whether natural or induced, according to the ISS. In Progetto Menopausa Italia, of 15,253 women aged at least 55 with spontaneous menopause, who had attended menopause clinics between 1997 and 1999, 1.8% had reached menopause before the age of 40, what the study calls premature ovarian failure, and 7.1% between 40 and 45. In that study premature ovarian failure was more common among women without children and among those who had always had irregular periods.

Is it normal to still have periods after 50?

Yes: the menopause usually arrives between the ages of 45 and 55, according to the ISS, so still having periods at 50–52 falls within the expected range. In three Italian studies the average age at menopause was between 50.2 and 51.2. We did not find a measure of how many Italian women reach menopause after 55.

What can bring the menopause forward?

  • Smoking. In two Italian studies, smokers reached menopause slightly earlier: by half a year in the ICARUS study, 50.4 years against 50.9, and by a tenth of a year in Progetto Menopausa Italia, 51.1 against 51.2. In the study of menopause before the age of 45, smoking made no difference.
  • Children. In the ICARUS study, women without children reached menopause at 50.0 years, those with children between 50.4 and 51.2.
  • Other factors. In Progetto Menopausa Italia, a lower body mass index and an early first period were also associated with a slightly earlier menopause, but the authors stress that in absolute terms the effect of these factors is very small.
  • Induced menopause. Induced menopause, for example from surgery that removes the ovaries, has to be considered separately: in Onda's 2014 survey it affected 6% of the women in menopause.

What are the 4 stages of menopause?

The menopause is one precise day, the last period, and it can only be recognised in hindsight: according to the ISS, we speak of menopause when there has been no period for at least 12 consecutive months. In common usage, four stages are distinguished around that day.

The four stages of menopause: what happens, when and how long each lasts.
StageWhat happensWhen, usuallyHow long it lasts
PremenopausePeriods are still regular, but hormones start to fluctuate and the first signs appear: disturbed sleep, aches and pains, mood swingsfor most women after the age of 40until the first lasting change in the cycle
PerimenopausePeriods change and hot flushes and night sweats appear. The sign: the length of two consecutive cycles differs, persistently, by at least 7 days; in the late stage, 60 days or more go by without a periodin an American study, at a median age of 47.5a few months or years
MenopauseThe last period, recognised after 12 months with no periodsbetween the ages of 45 and 55, at around 51 on averageone day
PostmenopauseEverything that comes after the last period: the symptoms of hormone deficiency remain and, over the years, the risks to bones, heart and urinary tractafter the menopausethe rest of a woman's life

The cycle criteria for perimenopause are the international STRAW+10 ones, from 2012. In everyday language “premenopause” covers the first two stages together, as in our other articles; the medical term for those years is perimenopause, or the menopausal transition. To tell whether you are in premenopause, your cycle and symptoms count for more than your age.

How long does the menopause last?

The menopause itself is one day. What lasts is the transition that comes before it and, for many women, the symptoms:

  • Perimenopause lasts a few months or years, differing from woman to woman, according to the ISS. In an American study from 1992 of women aged 45 to 55, followed for five years, it began at a median age of 47.5 and lasted almost 4 years.
  • Hot flushes and night sweats last a median of 7.4 years, and more than 11.8 years when they already appear in premenopause or at the start of perimenopause, in an American study from 2015 of 1,449 women with hot flushes on at least 6 days every two weeks.
  • Problems linked to the fall in oestrogen can last for years even after the last period, according to the ISS.
  • Postmenopause lasts for the rest of life: for a woman who turns 51, ISTAT calculates another 35.6 years on average (2024 life table), an approximation.

What symptoms do women in menopause have?

In 2024 an Onda survey of 600 women aged 45 to 55 asked which problems they experience:

  • sleep disturbances: 76%
  • hot flushes or excessive sweating: 73% (54% of all those surveyed experience them in a moderate or severe form)
  • tiredness: 73%
  • weight gain: 68%
  • joint and muscle pain: 67%

Among working women aged 45–65, more than six in ten experience significant symptoms of a physical, emotional or cognitive kind, according to Onda's 2025 survey “Menopausa e lavoro”.

Chronic pain, present for at least three months, affects 25.0% of women aged 45 to 54 against 17.6% of men of the same age, according to an ISS analysis of data from the 2019 ISTAT survey.

How much does the menopause affect work?

  • Performance. In Onda's 2025 survey, almost seven in ten working women aged 45 to 65 say their symptoms have a medium or high impact on their performance, but only 14% have taken time off or sick days.
  • Quality of work. In Deloitte Italia's 2026 report, about one in two female employees in perimenopause or menopause reports a worsening of working life, mainly because of tiredness (49%) and stress (43%).
  • Absences. In the same Deloitte report, one female employee in four has been absent for reasons linked to the menopause. In its 2025 survey Onda puts the cost of the days of absence alone at about €112 million a year, assuming one day for each period of time off: the estimate does not count the performance lost by those who work anyway.
  • Companies. 40% of the female employees surveyed by Deloitte believe that their company has no initiatives on the menopause; among men, 18% think so.

How much is it talked about?

  • At work. In Onda's 2025 survey, 37.7% of working women aged 45 to 65 have not talked about their symptoms with anyone at work, and another 11.6% work alone. Among the female employees surveyed by Deloitte in 2026, only one in six has talked about it with their manager.
  • At school. For 61% of the male and female workers surveyed by Deloitte, the menopause has never been covered at school, and for 48% never at work; 77% would like it to be talked about more.
  • In society. In a 2026 survey by EngageMinds HUB, 46% of Italians, men and women of all ages, consider the menopause still a taboo, and only 19% think that women's needs are given sufficient consideration at work and in services.
  • With the doctor. In Onda's 2024 survey, 22% of the women surveyed have hot flushes and have not talked about them with any healthcare professional. In a Censis survey of 1,028 women aged 45 to 65, published in 2021, 50.4% had not turned to the Italian National Health Service.

How many women are on hormone therapy?

In Italy there is no official figure on how many women use hormone therapy for the menopause. AIFA's annual reports on the use of medicines, the Rapporti OsMed, give by sex and age the class “genito-urinary system and sex hormones”, but not the individual menopausal hormone therapies: there is no usage rate. The numbers available come from surveys of different samples, and should not be compared with one another as a series over time:

  • 7.6% of women aged 45 to 65 said they were taking hormone therapy, in a Censis survey of 1,028 women published in 2021.
  • 5% of women in menopause with symptoms had turned to hormone therapy in 2022; it had been offered to 25% of women in menopause, and 7% had accepted it. The survey, by Elma Research for Onda, involved 315 women.
  • 45% of women with severe hot flushes use no product to manage them; those who use one mostly turn to supplements, in Onda's 2024 survey.

And in other European countries? Some countries count the women on hormone therapy from prescription data. These are official figures, collected differently from the Italian surveys, and they serve as a reference rather than as a direct comparison:

  • France: in 2025, 4.4% of women aged 45 to 60 collected a systemic hormone therapy reimbursed by the health system at least once, according to EPI-PHARE for the French medicines agency, ANSM.
  • Sweden: the share of women over 45 who collect systemic oestrogens from the pharmacy went from 5.1% in 2021 to 8.4% in 2025, with large differences: 3.2% in the most disadvantaged areas, 12.1% in the most favoured ones, according to the Swedish health authority, Socialstyrelsen.
  • Spain, Portugal and Greece: we did not find a recent national figure.

What happens to health after the menopause?

  • Heart. According to ISTAT, in 2023 diseases of the circulatory system caused 33% of deaths among women in Italy, at all ages, against 23% caused by cancers. Yet in Onda's 2024 survey only 41% of women aged 45 to 65 link the menopause to a higher cardiovascular risk, and 66% feel the need for more information on the subject. 58% have talked about the menopause with a doctor; about cardiovascular issues, 41%.
  • Bones. The Ministry of Health estimates that in Italy osteoporosis affects about 5 million people, and that 80% of them are postmenopausal women. Among women, 12.9% say they have it, and 45.4% of those over 74, according to 2023 ISTAT data reported by the ISS.
  • Fractures. In 2023 Italian hospitals recorded 95,808 surgical admissions for femur fracture, men and women; the share of patients over 65 operated on within 48 hours rose to 59% (median value across hospitals), from 48% in 2021, according to AGENAS.
  • Chronic diseases. 18.0% of women aged 45 to 54 and 32.0% of those aged 55 to 64 report having three or more chronic diseases, in the European health survey carried out by ISTAT in 2019.
  • Weight. Among women aged 55–64, 31.0% are classed as overweight and 12.0% as obese, based on self-reported weight and height: these are 2023 ISTAT data processed by Osservasalute.

What do the data from other countries say?

Three findings from other countries that do not yet have an Italian equivalent:

  • Sweden: women who had greater access to menopause care lost less income from work in the first three years after the menopause, in a 2026 analysis by the Institute for Fiscal Studies.
  • United States: working days lost to menopause symptoms cost $1.8 billion a year, according to a 2023 study by the Mayo Clinic.
  • World: closing the women's health gap could grow the global economy by at least $1 trillion a year by 2040, in a 2024 estimate by the World Economic Forum and the McKinsey Health Institute.

How we collected these data

We looked for data published by Italian sources from 2021 onwards: ISTAT, Istituto Superiore di Sanità, the Ministry of Health, AIFA, AGENAS, Osservasalute, Fondazione Onda, scientific societies, universities and research centres. Every number was re-read in the source listed; where we read only the abstract of a study, or a page that reports an ISTAT figure, the source listed is the one we read. We report the estimate of 17 million women as the Fondazione Onda press release cites it, which refers to Federfarma: the original Federfarma press release was not reachable. For every figure we give the year, and the funder when the source states it.

The exception is the age at menopause, which in Italy was measured by studies with data collected between 1995 and 2014. For the stages of menopause we use the 2020 page of the Istituto Superiore di Sanità, the international STRAW+10 criteria and studies from other countries, labelled as such.

You can cite these numbers by giving the original source and this page: Medyca, “Menopause in Italy: the numbers”, medyca.it. If you find a more recent figure or a mistake, write to us at info@medyca.it.

Who is Medyca

Medyca is the medical service founded and run by Dr Cristina Lenzi, dedicated to women who want to tackle perimenopause and menopause through a personalised bioidentical hormone pathway and a complete view of their health. Over 1,000 patients cared for. The practice is in Siena. We care for patients from anywhere in Italy, and from abroad, by video call.

Find out more on our blog

Sources

In order of appearance on the page.

  1. Fondazione Onda ETS, press release of 28/05/2025 on the presentation to the Chamber of Deputies of the policy document: women in menopause and perimenopause, with a reference to an estimate by Federfarma (press release of 18/10/2024).
  2. ISTAT via Eurostat, resident population by sex and age at 1 January 2025 (table demo_pjangroup).
  3. Fondazione Onda, “La menopausa nella vita delle donne”, March 2024, 600 women aged 45 to 55: symptoms, hot flushes and healthcare professionals, use of products.
  4. Fondazione Onda, “Menopausa e lavoro”, October 2025, 1,576 working women aged 45 to 65: symptoms, performance, time off, cost of absences, who it is talked about with.
  5. Vaccaro et al., “What women think about menopause: an Italian survey”, Maturitas, 2021, Censis survey of 1,028 women aged 45 to 65: use of the Italian National Health Service, hormone therapy.
  6. “Salute e benessere in menopausa: l'importanza di un approccio multidisciplinare e di una presa in carico personalizzata”, policy document in collaboration with Fondazione Onda ETS, with an unconditional contribution from Astellas, May 2025: women aged 45 to 75 and over 75, based on ISTAT data of January 2024.
  7. Maria Rosaria Campitiello, Ministry of Health, address to the Chamber of Deputies of 30/06/2026, as reported by Adnkronos: women in menopause, 450,000 a year.
  8. ISTAT, life tables, 2024 (final) and 2025 (estimate): life expectancy at birth and at 51, women.
  9. ISTAT, Indicatori demografici 2024, 31/03/2025: estimate of 2024 life expectancy.
  10. ISTAT, Indicatori demografici 2025, 31/03/2026: estimate of 2025 life expectancy.
  11. ISTAT, Previsioni della popolazione residente, delle famiglie e delle forze lavoro, base 1/1/2025, 31/08/2026: projected life expectancy at birth, median scenario (values in the ISTAT database, demographic indicators).
  12. ISTAT, Rapporto Bes 2026, Health chapter: life expectancy in good health and the difference between women and men in average life expectancy, provisional estimate 2025.
  13. Istituto Superiore di Sanità, ISSalute, “Menopausa”, page updated on 18/05/2020: age, menopause before 45, definition, duration of the irregularity.
  14. Medyca, article on the first symptoms of premenopause, 21/09/2026: the first signs for most women after the age of 40.
  15. Progetto Menopausa Italia Study Group, Parazzini, “Determinants of age at menopause in women attending menopause clinics in Italy”, Maturitas, 2007: 31,834 women, data 1997–2003.
  16. Amigoni et al., study of 16,916 women seen by their GP, Climacteric, 2000: data 1997.
  17. Fondazione Onda, “Donne italiane e menopausa”, summary of results, survey of June 2014 of 626 women aged 45 to 65: self-reported average age at menopause, induced menopause.
  18. Fondazione Onda, “Benessere in menopausa”, October 2014, booklet drawn from the 2014 survey, with the support of Fidia Farmaceutici.
  19. Progetto Menopausa Italia Study Group, “Premature ovarian failure: frequency and risk factors”, BJOG, 2003: 15,253 women, data 1997–1999.
  20. ICARUS Study Group, Meschia et al., “Determinants of age at menopause in Italy”, Maturitas, 2000: 4,300 women.
  21. British Menopause Society, “What is the menopause”, January 2026: average age in the United Kingdom.
  22. Harlow et al., STRAW+10, Journal of Clinical Endocrinology & Metabolism, 2012: menstrual cycle criteria for the menopausal transition.
  23. McKinlay et al., “The normal menopause transition”, Maturitas, 1992: age and duration of perimenopause (United States).
  24. Avis et al., duration of hot flushes in the SWAN study, JAMA Internal Medicine, 2015 (United States).
  25. Istituto Superiore di Sanità, Rapporti ISTISAN 23/28, 2023, based on EHIS 2019 data: chronic pain.
  26. Deloitte Italia, Women's Health Impact Report, May 2026, 1,600 employees: working life, absences, company initiatives, discussion at school and at work.
  27. EngageMinds HUB, Università Cattolica, “Sessualità, menopausa e benessere”, July 2026: the menopause as a taboo.
  28. AIFA, Rapporto OsMed 2025: use of medicines by sex and age.
  29. Fondazione Onda, press release and presentation of the results, March 2022, Elma Research survey of 315 women, with a contribution from Theramex: hormone therapy.
  30. EPI-PHARE for ANSM, report on menopausal hormone therapy, 25/06/2026 (France).
  31. Socialstyrelsen, press release on hormone therapy, 2026 (Sweden).
  32. ISTAT, Cause di morte, anno 2023, May 2026.
  33. Fondazione Onda, “Donne, menopausa e problematiche cardiovascolari”, summary, September 2024, 600 women aged 45 to 65.
  34. Ministry of Health, “Osteoporosi”, page updated on 01/03/2023.
  35. Istituto Superiore di Sanità, ISSalute, “Osteoporosi”, based on 2023 ISTAT data.
  36. AGENAS, Programma Nazionale Esiti 2024, 2023 data: femur fractures.
  37. ISTAT, EHIS 2019 survey, tables: chronic diseases.
  38. Osservasalute, Rapporto 2025, based on 2023 ISTAT data: overweight and obesity.
  39. Institute for Fiscal Studies, “The menopause penalty”, January 2026 (Sweden).
  40. Faubion et al., Mayo Clinic, cost of menopause symptoms at work, Mayo Clinic Proceedings, 2023 (United States).
  41. World Economic Forum and McKinsey Health Institute, “Closing the Women's Health Gap”, January 2024.